These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 7694687
1. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Miwa H, Kita K, Nishii K, Morita N, Takakura N, Ohishi K, Mahmud N, Kageyama S, Fukumoto M, Shirakawa S. Blood; 1993 Dec 01; 82(11):3445-51. PubMed ID: 7694687 [Abstract] [Full Text] [Related]
2. Biological characteristics of CD7(+) acute leukemia. Miwa H, Nakase K, Kita K. Leuk Lymphoma; 1996 Apr 01; 21(3-4):239-44. PubMed ID: 8726405 [Abstract] [Full Text] [Related]
4. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta. Yoneda N, Tatsumi E, Teshigawara K, Nagata S, Nagano T, Kishimoto Y, Kimura T, Yasunaga K, Yamaguchi N. Am J Hematol; 1994 Apr 01; 45(4):310-20. PubMed ID: 7513945 [Abstract] [Full Text] [Related]
5. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S. Blood; 1993 May 01; 81(9):2399-405. PubMed ID: 7683218 [Abstract] [Full Text] [Related]
6. CD7-positive acute myeloid leukemia: further evidence of cellular immaturity. Kondo S, Okamura S, Harada N, Ikematsu W, Kawasaki C, Fukuda T, Kubota A, Shimoda K, Harada M, Shibuya T. J Cancer Res Clin Oncol; 1992 May 01; 118(5):386-8. PubMed ID: 1374757 [Abstract] [Full Text] [Related]
7. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukaemia. Kita K, Nishii K, Ohishi K, Morita N, Takakura N, Kawakami K, Miwa H, Shirakawa S. Leukemia; 1993 Aug 01; 7(8):1184-90. PubMed ID: 7688838 [Abstract] [Full Text] [Related]
9. p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia. Abo J, Inokuchi K, Dan K, Nomura T. Blood; 1993 Nov 01; 82(9):2829-36. PubMed ID: 7693050 [Abstract] [Full Text] [Related]
12. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreeff M. Blood; 1992 Dec 01; 80(11):2729-34. PubMed ID: 1360266 [Abstract] [Full Text] [Related]
13. [Cytokine in phenotypic analysis of leukemia/lymphoma: suppression of gene expression of myeloperoxidase by IFN-gamma and subset of AML M1 defined by CD45RO+/RA-, CD7(-), CD34(-) and non-inducible HLA-DR antigen]. Tatsumi E, Yoneda N, Kawano S, Yamaguchi N. Rinsho Byori; 1993 Apr 01; 41(4):377-83. PubMed ID: 7688832 [Abstract] [Full Text] [Related]
14. Biological characteristics of CD7 positive acute myelogenous leukaemia. Eto T, Akashi K, Harada M, Shibuya T, Takamatsu Y, Teshima T, Niho Y. Br J Haematol; 1992 Nov 01; 82(3):508-14. PubMed ID: 1283077 [Abstract] [Full Text] [Related]
16. [P-glycoprotein expression in hematological malignancies]. Yamaguchi M, Mizutani M, Miwa H, Kita K. Rinsho Ketsueki; 1995 Jun 01; 36(6):567-72. PubMed ID: 7643452 [Abstract] [Full Text] [Related]
17. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome. Jiang EZ, Chang YJ, Lee JW, Lee WK, Kim JS, Sohn SK, Lee KB, Suh JS. J Korean Med Sci; 1998 Dec 01; 13(6):617-22. PubMed ID: 9886170 [Abstract] [Full Text] [Related]
18. Clinical and biologic characteristics of CD7+ acute myeloid leukemia. Our experience and literature review. Shimamoto T, Ohyashiki JH, Ohyashiki K, Kawakubo K, Inatomi Y, Fujieda H, Nakazawa S, Kimura N, Miyauchi J, Toyama K. Cancer Genet Cytogenet; 1994 Mar 01; 73(1):69-74. PubMed ID: 7513604 [Abstract] [Full Text] [Related]